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1. Introduction 
Chlamydiae are obligate intracellular bacteria and consist of four species, including Chlamydia 
trachomatis, C. pneumoniae, C. psittaci and C. pecorum, which cause many types of diseases. 
The word chlamys is Greek for „cloaked“ or „draped“, descriptive of the intracytoplasmic 
inclusion bodies that are „draped“ around the host cell nucleus. 
C. trachomatis is a Gram-negative bacteria, therefore its cell wall components retain the 
counter-stain safranin and appear pink under a light microscope. Identified in 1907, C. 
trachomatis was the first chlamydial agent discovered in humans. 
Chlamydia trachomatis (CT) is one of the major bacterial agent of the sexually transmitted 
diseases (STDs) worldwide. It is a causative agent of urogenital, ocular and pneumonic 
infections, causing annually 92 million new infections worldwide. It is responsible for a 
wide range of infections, including trachoma (a chronic conjuctivitis, which is the leading 
preventable cause of blidness worldwide), newborn conjuctivitis, and genital infections in 
women and men. CT has a unique life cycle, dependent on the host cell's adenosine 
triphosphate (ATP) production, which differentiates it from all other microorganisms.  
Chlamydial genital infection is the most frequently reported infectious disease in the United 
States, and prevalence is highest in persons aged ≤25 years (Centers for Disease Control and 
Prevention CDC, 2009).   
Asymptomatic infection is common among both, women and men. The fact is that as many 
as 70 to 80% of women and up to 50% of men who are infected do not experience any 
symptoms. The most serious sequelae as the CT infection in women include pelvic 
inflammatory disease- PID, tubal infertility, chronic pelvic pain and ectopic pregnancy. 
In pregnant women, CT infection is associated with preterm birth and other complications 
such as stillbirth, premature rupture of membranes, and post-partum endometritis.  
Since chlamydial infections first become a reportable disease in the United States in 1986, the 
number of reported cases in both men and women has increased each year. It is currently 
estimated that about 4 million new chlamydial infections occur each year in the United 
States at an estimated annual cost exceeding $ 2.4 billion (CDC, 2003).   
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Worldwide, it is estimated that there are more than 50 million new cases CT infection 
annually (CDC, 2003).  
The prevalence of CT infection in sexually active adolescent women, the population 
considered most at risk, generally exceeds 10%, and in some adolescent and STD clinic 
populations of women, the prevalence can reach 40%.  
The incidence of asymptomatic infection, it's impact on individuals, and it's influence on the 
prevalence of disease in the community has led multiple professional organizations to 
recommend that all sexually active women aged 25 years and younger and all asymptomatic 
women at risk infection be screened for CT genital infection. Chlamydial infections may 
increase susceptibility to and transmission of human immunodeficiency virus-HIV in both 
women and men (Westrom et al., 1999).  
As far as Central and Eastern European (“CEE”) countries are concerned, the 
epidemiological picture of chlamydial genital infections cannot be reliably estimated since 
there is no systematic registration, prevalence studies are sporadic and methodologically 
hardly comparable, and prevention programs focusing on asymptomatic population are 
scarce. 
The incidence of chlamydial genital infections in CEE is estimated to be 21 to 276 cases per 
100,000 inhabitants. The public health importance of chlamydial genital infections lies in the 
fact that their prevalence is the highest in young population, that they are mostly 
asymptomatic and that, if left untreated, they may later result in chronic pelvic infl 
ammatory disease, sterility or ectopic pregnancy. 
Unfortunately, symptoms of genital infection are often completely absent or very mild 
among infected patients, especially women, creating a large reservoir of infected persons 
who continue transmission to new sexual partners. Because these infections are easy to 
diagnose and curable with a single dose of oral antibiotics, early detection and treatment are 
an important component of efforts to reduce the disease burden.   
Chlamydia is often found as a co-infection with gonorrhea in both women and men. 
Between 30 and 50% of patients who have gonococcal infections also have infection with C. 
trachomatis. However, because the background incidence of gonorrhea is so much lower 
(<0.5%), it is far less likely that a person infected with C. trachomatis will also have 
gonoccocal infection. In the National Longitudinal Study, only 0.3% of young adults were 
co-infected (Miller et al., 2004). Although screening for C. trachomatis is widely 
recommended among young adult women, little information is available regarding the 
prevalence of chlamydial infections in the general young adult population. Screening 
programs have been demonstrated to reduce both the prevalence of C. trachomatis infection 
and rates of PID in women (Scholes et al., 1996).  
Today chlamydial infections are diagnosed by simple, reliable and non-invasive tests, and 
the therapy of choice is a single dose of 1 g azithromycin, which has proven to be safe and 
effective, especially in acute infections. Azithromycin also proved to be the drug of choice in 
the treatment of chronic infections, chlamydial prostatitis, and in the treatment of major 
complications, such as pelvic inflammatory disease. 
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1.1 Facts 
1. Chlamydia is the most commonly reported bacterial infection, with an estimated four 
million new cases each year. 
2. Adolescents and adults are most commonly infected with C. trachomatis. 
3. Asymptomatic infection is common among both, women and men. 
4. Untreated chlamydial infections may lead to PID, ectopic pregnancy, and infertility. 
5. The purpose of at least annually screening all sexually active women aged 25 years and 
younger is to reduce the incidence of upper tract infection. 
2. Etiology 
Because of their unique developmental life cycle, all chlamydiae were placed into their own 
order, Chlamydiales, family Chlamydiaceae, within one genus, Chlamydia (Pudjitamoko et al., 
1997, as cited in Int J Syst Bacteriol, 1984). C. trachomatis is one of the four recognized species 
of the genus Chlamydia, with C. pneumoniae, C. psittaci and C. pecorum. Chlamydia species are 
readily identified and distinguished from other chlamydial species using DNA-based tests 
and on the basis unique growth cycle. Chlamydia psitaci is a common pathogen of avian 
species and domestic mammals, but only involves humans as a zoonosis. Chlaymdia 
pneumoniae is a common respiratory pathogen of humans that has been implicated as a 
possible cause of coronary artery disease. Chlamydia pecorum is a pathogen of domestic 
animals. Some C. psitacci strains are sexually transmitted in their natural hosts, and one-the 
guinea pig inclusion conjuctivitis (GPIC) agent –may offer a potenitially useful animal 
model for the study of sexually transmitted chlamydial infections. Molecular techniques 
such as PCR or DNA hybridization or the use of monoclonal antibodies are required to 
differentiate the species.  
There are 15 serovars of C. trachomatis, which are divided into the trachoma serotypes A, B, 
Ba, and C, the oculogenital serovars, D-K, and the lymphogranuloma venereum (LGV) 
serovars L1-L3 (table 1.). Most strains of C. trachomatis are recognized by monoclonal 
antibodies (mAbs) to epitopes in the VS4 region of MOMP (major outer membrane protein). 
Serovars can be distinguished by serological typing using monoclonal antibodies or by 
molecular gene typing methods. Typing is useful for epidemiological studies, which focus 
on transmission and geographical differences. In the developed world, the oculogenital 
strains are predominantly the strains that are routinely prevalent, while trachoma is a 
sequelae of ocular disease in developing countries and countinues to be a leading cause of 
preventable blidness. LGV is sporadic in North America and Europe, and endemic in Africa, 
India, Southeast Asia, South America, and the Caribbean. Occasional cases or clusters of 
cases suggest ongoing low-level transmission in these areas. Few countries  require official 
notification of LGV cases, and the lack of standard diagnostic criteria renders reported cases 
somewhat suspect. Likeother sexually transmitted diseases LGV is more common in urban 
than in rural areas, among the sexually active, and among the lower socioeconomic groups. 
Much of the reported epidemiology on LGV was based on cases diagnosed using clinical 
criteria or the results of serologic tests and/or Frei skin tests that were not specific for the 
disease.  
Urogenital chlamydial infections occur primarily among young sexually active persons. 
Prevalence rates encompass all socioeconomic groups and geographical areas, and may 
range from 5-20% in various groups of young adults (Eng & Butler, 1997). 
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Disease/Syndrome Biovar Most frequent serovars 
Trachoma trachoma A, B, Ba, C 
Inclusion conjunctivits trachoma D, Da, E, F, G, H, I, Ia, J, K 
Urethritis, cervicitis, 
salpingitis 
 (pharyngitis, otitis media) 
trachoma B, C, D, E, F, G, H, I, K, L3 
Lymphogranuloma 
venereum (syn. 
Lymphogranuloma 
inguinale, lymphopathia 
venerea, Favre-Durand-
Nicolas disease) 
lymphogranuloma 
venereum 
L1, L2, L2a, L3 
Table 1. Human infections caused by Chlamydia trachomatis. 
3. Chlamydial biological cycle  
Chlamydiae are obligate cell parasites and cannot be cultured on arteficial media. They have 
the ability to establish long-term associations with host cells. They are also restricted to an 
intracellular life style because chlamydiae lack the ability to synthesize high-energy 
compounds. When an infected host cell is starved for various nutrients such as amino acids 
(tryptophan) iron, or vitamins, this has a negative consequence for Chlamydiae since the 
organism is dependent on the host cell for these nutrients. They depend on the host cell to 
supply them with ATP and necessary nutrients.   
It is developmental cycle of chlamydiae that sets them apart form all other bacteria. There 
are some differences in inclusion morphology within the chlamydiae, but all species appear 
to have essentially identical developmental cycles.  
They go through two stages in their reproductive cycle; the elementary bodies (EBs) are 
optimized to survive outside of host cells. In the form of the reticular bodies (RBs), the 
chlamydiae reproduce inside the host cells. This cycle involves an alternation between two 
highly specialized morphologic forms, one adopted to an intracellular and the other to an 
extra cellular environment.  
The cycle may be divided into several steps: (1) initial attachment of the infectious 
particle, or elementary body, to the host cell; (2) entry into the cell; (3) morphological 
change to the reticulate particle, with intracellular growth and replication; (4) 
morphologic change of reticulate particles to Ebs; and finally (5) release of the infectious 
particles (figure 1.). 
The entire cycle takes place within a chlamydia –modified intracellular vacuole, which 
undergoes a large increase in size.  
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Fig. 1. Chlamydial Biological Cycle  (Jones et al.,1994). 
3.1 Elementary bodies 
The round to oval, optically dense elementary bodies have a diameter 300 nm. Infection 
begins when EBs attach to specific receptors found on nonciliated columnar or cuboidal 
epithelium of the host. This type of epithelium is located in the endocervix, endometrium, 
fallopian tube, and urethra, making those sites vulnerable to infection.  
3.2 Reticulate bodies  
After phagocytosis, the EB exists within a cytoplasmic vacuole or phagosome, where it is 
protected from host defense systems. Within the phagosome, the EB transforms into a 
reticulate body in order to myltiply. It has a diameter of aproximately 1000 nm. At the end 
of the life cycle, RBs are transformed back into EBs. The cell breaks open and releases the 
EBs to continue the cycle by attaching themselves to new host cells.  
4. Prevalence and Incidence 
Chlamydial genital infection is the most frequently reported infectious disease in the United 
States, and prevalence is highest in persons aged 25 years (CDC, 2009). The Centers for 
Diseases Control and Prevention (CDC), Atlanta, GA,  has not changed its age cutoff, and 
thus continues to recommend annual chlamydia screening of sexually active women aged 
25 years. The CDC estimates that 2.8 million new cases occur in the United States each year 
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(CDC, 2005). Nearly 75% of cases occur in the 15-to 24-year-old age group (Grosecloseet et 
al., 1999). The World Heath Organization (WHO)  estimated that 92 million new infections 
with C. trachomatis occured worldwide in 1999 (WHO, 2001). The prevalence of active 
infection in sexually active, asymptomatic, non-pregnant women in the general population 
is between 3 and 5% (Sweet & Gibbs, 2002). The highest age-specific rates were reported in 
women age 15-26. In the general population, men have the same prevalence of chalmydial 
infections as women (3-5%). Among men, the highest rates occurs in 20- to 24- year-old 
(CDC, 2005). However, accurate time trends in the incidence of chlamydia are difficult to 
define because of changes in reporting, increased detection due to improved laboratory tests 
and increasing laboratory surveillance. Gerbes et al. (Gerbes et al., 1998) estimated  that the 
average annual incidence rates for people aged 15 to 49 years were similar in North 
America, Western Europe and Australasia at 2146/100,000 for males and 3073/100,000 for 
females in 1995.  
Chlamydia causes more than 250,000 cases of epididymitis in the U.S. each year. Chlamydia 
causes 250,000 to 500,000 cases of PID every year in the United States. Women infected with 
chlamydia are up to five times more likely to become infected with human 
immunodeficiency virus (HIV), if exposed. 
5. Risk factors 
The risk factors for chlamydial infection include: age younger than 26, low socioeconomic 
status, minority group member, contraceptive use, age at first intercourse, multiple sexual 
partners and new partners, and other risk factors as well.  
Younger age is shown consistently to be asociated with increased risk of chlaymdial 
infection among the sexually active population. Age is an important risk factor because C. 
trachomatis typically infects the columnar cells of the cervix; in younger women, columnar 
cells are more likely to be on the ectocervix (ectopy), where they can be exposed to semen 
carrying the organism. As women age, the columnar cells are located higher in the cervical 
canal. Combination hormonal contraceptive use apparently increases cervical ectopy and 
has been a proposed risk factor for chlamydial infection (Jocobson et al., 2000). The highest 
incidence rates of infection are reported in adolescents and young adults in Canada and the 
United States. Differences in the prevalence of infection between adolescents and adults are 
also often attributed to differences in sexual behaviours.  
Race/ethnicity and socioeconomic status are often considered together because they are 
strongly interrealted (van de Hoek, 1999). Only 10 of 23 studies in females and one of four 
studies in males indicated a higher risk of chlamydial infection in nonwhite people 
compared with white people in multivariate analysis. Socioeconomic status was not 
associate with chlamydia in multivariate analysis using any measure for males and females, 
including employment status income level of parents education use of  Medicaid  or 
occupation. 
Multiple partnerships may increase the likelihood of encountering a sexually transmitted 
pathogen through the increased probability of choosing a partner with infection, while 
having new or casual sexual contacts may be related to increased risk because of a reduced 
familiarity between partners. 
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The relationship between the use of condoms and other barrier contraceptives (diaphragm), 
and genital chlamydial infection is inconsistent across the studies. Use of a barrier method 
was shown to be associated with reduced risk of infection compared with the use of other 
methods of contraception in two of five studies in females. 
Age at first intercourse may be casually related to sexually transmitted infections through 
the biological mechanisms affecting adolescents that and also be an indicator of other 
aspects of sexual activity that will directly increase risk, including multiple partnerships and 
the recruitment of nonregular partners. 
6. Pathogenesis, infectivity and transmission 
Although the pathologic consequences of infection are well established, the mechanism of 
chlamydia-induced tissue damage are not fully understood. Emerging knowledge of the 
immune response to infection suggests that many of the complications of chlamydial 
infection are accompanied by important alterations in immunoregulation; both antibody-
mediated and cell-mediated immune effectors may be significant in eliminatory or limiting 
chlamydial infection. 
The ways of spreading are different; sexually, perinatal, although are not exclusive the other 
ways of transmission through the chloride water of swimming pool, wet towel as well as the 
possibility of intrahospital infections, by gynecological exam, are not keep the necessary 
protection measures. It is supposed, statistically, that about 10% percent of women in 
reproductive age are infected with C. trachomatis.  
C. trachomatis is the most common sexually transmitted bacterial agent, which infects only 
humans. The single exposure male-to-female transmission rate has been estimated to be 
40%, and the female-to-male transmission rate has been estimated to be 32%  (Sweet & 
Gibbs, 2002). Other investigators have found that transmission rates between sexes are 
equivalent    (Quinn et al., 1996).  
Vertical transmission of C. trachomatis is more efficient than horizontal transmission. More 
than 60% of newborns who delivered through a chlamydia-infected cervix will aquire the 
infection  (Sweet & Gibbs, 2002). 
As well as the infection with human papilloma virus, chlamydial infection is very important 
promoter of cervical intraepithelial neoplasm, which result with bad Papanicolaou test, with 
salpingitis with consequently opturation tuba incompletely or completely, which finally 
results as extrauterine pregnancy and sterility.  During pregnancy, C. trachomatis causes 
disorders and ruptures of the fertile membranes with consequent delayed spontaneous 
abortion or the earlier delivery.  
7. Clinical manifestations 
Genital infections caused by C. trachomatis closely parallel those due to N. gonorrhoeae in 
terms of clinical manifestations. Both preferentially infect columnar or transitional 
epithelium of the urethra, with extension to the epididymis; the endocervix, with extension 
to the endometrium, salpinx, and peritoneum; and the rectum. C. trachomatis are naturally 
found living only inside human cells. Chlamydia can be transmitted during vaginal, anal, or 
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oral sex, and can be passed from an infected mother to her baby during vaginal childbirth. 
Between half and three-quarters of all women who have a chlamydia infection of the neck of 
the womb (cervicitis) have no symptoms and do not know that they are infected. 
C. trachomatis serovars A, B, Ba, and C are associated with endemic trachoma, the most 
common preventable form of blidness, while serovars L1, L2, and L3 are associated with LGV. 
Serovars D through K are the major causes of nongonococcal urethritis and epididymitis in 
men and may induce Reiter's syndrome, proctitis, and conjuctivitis in both men and women 
and cervicitis, urethritis, endometritis, with salpingitis with tubal obstruction which could be 
complete or incomplete, and perihepatitis in women. During pregnancy CT can cause 
„premature“ rupture of membranes, spontaneous abortions and preterm delivery. 
7.1 Trachoma 
Trachoma is a follicular keratoconjuctivitis. The disease occurs in all climatic zones, 
although it is more frequent in warmer, less-developed countries. The pathogen is 
transmitted by direct contact and indirectly via objects in daily use. Untreated, the initially 
acute inflammation could develop a chronic course lasting months or years and leading to 
formation of a corneal scar, which can than cause blidness.  
The laboratory diagnostics procedure involves detection of C. trachomatis in conjuctival 
smears using direct immunofluorescence microscopy. The fluorochrome-marked 
monoclonal antibodies are directed against the MOMP of C. trachomatis.  
The pathogen can also be grown in cell cultures. The therapeutic method of choice is 
systemic and local application of tetracyclines over a period of several weeks.  
Chlamydia conjunctivitis or trachoma is a common cause of blindness worldwide. The 
WHO estimates that it accounted for 15% of blindness cases in 1995, but only 3.6% in 2002 
(WHO, 2002).  
7.2 Inclusion conjuctivitis 
This is an acute, purulent papillary conjuctivits that may affect neonates, children, and 
adults (swiming-pool conjuctivitis). Newborn children are infected during birth by 
pathogenes colonizing the birth canal. Untreated, a pannus may form as in trachoma, 
followed by corneal scarring. Laboratory diagnosis and therapy as in trachoma. 
7.3 Genital infections 
Chlamydial infections of the genital tract have a worldwide distribution and are prevalent 
both in the industrialized countries and in the developing world. C. trachomatis as the 
bacterial agent is responsible for the huge number of genital infections, which is spreading 
especially among younger (table 2.). Adults are defined as persons between 15 and 49 years 
of age. Almost four million new cases of chlamydial infections on genital plane are 
registrated every year in the United States, and three million in Europe (CDC, 1997). 
Epidemiological investigations of a large number of women in the United States and 
Scandinavia confirm chlamydiae as the most prevalent STDs for developed countries.  
Considered the prevalence infections, hard consequences and huge bills for the treatment in 
the United States is implement screening methods, which include persons with high risk:  
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- Persons with anamnestic history of STDs; 
- Young persons sexually active; 
- Promiscuity persons; 
- Male with lymphogranuloma infection; 
- Newborns, 
- Reiter was diagnosed in younger males.  
 
Women   
Cervicitis Perihepatitis Preterm labor 
Urethritis Conjunctivitis Preterm delivery 
Acute urethral 
syndrome Ectopic pregnancy 
Premature rupture of 
membranes 
Proctitis Infertility Postpartum endometritis 
Endometritis Chronic pelvic pain  
Salpingitis Reiter' s syndrome  
   
Men   
Urethritis Proctitis  
Epididymitis Infertility  
Prostatitis Conjunctivitis  
Reiter' s syndrome   
   
Newborns   
Conjunctivitis Pneumonia  
Otitis media   
Table 2. Clinical manifestations of Chlamydia trachomatis. 
In women, C. trachomatis can cause urethritis, proctitis, or infections of the genital organs. It 
has even been known to cause pelvioperitonitis and perihepatitis. Massive perinatal 
infection of a neonate may lead to an interstitial chlamydial pneumonia.  
C. trachomatis is responsible for 30 to 60% of cases of nongonococcal urethritis (NGU) in 
men. Possible complications include prostatitis and epididymitis. The pathogens are 
communicated by venereal transmission. The source of infection is the female sexual 
partner, who often shows no clinical symptoms. 
Urogenital chlamydial infections occur primarily among young sexually active persons. 
Prevalence rates encompass all socioeconomic groups and geographical areas, and more 
range from 5-20% in various groups of young adults (Eng & Butler, 1997; Tamm, 1999). 
Because symptoms are absent in most infected individuals, the prevalence in population 
groups may be severely underestimated. So, widespread screening of individuals at greatest 
risk, e.g. those individuals who are young, sexually active, and have new or multiple 
partners, has been recommended. 
7.3.1 Genital infections in women  
Genital infections caused by the C. trachomatis is the most frequently reported STD's 
worldwide, with the highest prevalence in aged category of 25 years (CDC, 2009). In 
women, C. trachomatis has been shown to cause both lower and upper genital tract 
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infections.  Untreated, chlamydial infection can lead to severe reproductive complications. 
Chlamydia is known as the "silent epidemic" because in women, it may not cause any 
symptoms in 75% of cases, and can linger for months or years before being discovered. 
Symptoms that may occur include unusual vaginal bleeding or discharge, pain in the 
abdomen, painful sexual intercourse (dyspareunia), fever, painful urination or the urge to 
urinate more frequently than usual (urinary urgency).  
C trachomatis is an important causal agent in pelvic inflammatory disease, with sequelae 
including infertility, ectopic pregnancy, and chronic pelvic pain. Up to two thirds of cases of 
tubal-factor infertility and one third of cases of ectopic pregnancy may be attributable to C. 
trachomatis infection.  
Chlamydial infection during pregnancy is associated with a number of adverse outcomes of 
pregnancy including preterm labor, premature rupture of the membranes, low birth weight, 
neonatal death, and postpartum endometritis. Chlamydial infection during pregnancy may 
be transmitted to the infant during delivery.  
An infant born to a mother with active infection has a risk of acquiring infection at any 
anatomical site of 50 to 75%. Approximately 30 to 50% of infants born to chlamydia-positive 
mothers will have conjunctivitis, and at least 50 percent of infants with chlamydial 
conjunctivitis will also have nasopharyngeal infection. Chlamydial pneumonia develops in 
about 30% of infants with nasopharyngeal infection.  
7.3.2 Genital infections in men 
In men, the most common clinical manifestation of C. trachomatis infection is nongonococcal 
urethritis. In fact, C. trachomatis causes approximately 35 to 50 % of all cases of 
nongonococcal urethritis in heterosexual men. Symptoms of nongonococcal urethritis may 
develop after an incubation period of 7 to 21 days and include dysuria and mild-to-
moderate whitish or clear urethral discharge. In most cases, physical examination reveals no 
abnormalities other than the discharge. Other clinical syndromes in men include acute 
epididymitis, acute proctitis, acute proctocolitis, conjunctivitis, and Reiter's syndrome. Male 
infertility, chronic prostatitis, and urethral strictures are possible results of infection. Both 
Reiter's syndrome (urethritis, conjunctivitis, arthritis, and mucocutaneous lesions) and 
reactive tenosynovitis or arthritis (without the other components of Reiter's syndrome) have 
been associated with genital C. trachomatis infection. Infection with C. trachomatis is also 
believed to be a cofactor for the transmission of human immunodeficiency virus in both men 
and women  (Nelson & Helfand, 2001). 
 If left untreated, it is possible for chlamydia in men to spread to the testicles causing 
epididymitis, which in rare cases can cause sterility if not treated within 6 to 8 weeks. 
Chlamydia is also a potential cause of prostatitis in men, although the exact relevance in 
prostatitis is difficult to ascertain due to possible contamination from urethritis.  
7.4 Lymphogranuloma venereum 
Lymphogranuloma venereum-LGV is distinct venereal disease caused by three serotypes of 
C. trachomatis that are not associated with other chlamydial infections.  
Lymphogranuloma venereum is frequently observed in the inhabitants of warm climatic 
zones and occurs principally in South America and Africa. The disease is uncommon in 
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North America, but outbreaks have occurred. A herpetiform primary lesion develops at the 
site of invasion in the genital area, which then becomes an ulcus with accompanying 
lymphadenitis. Laboratory diagnosis is based on isolating the proliferating pathogen in cell 
cultures from purulent material obtained from the ulcus or from matted lymph nodes. The 
antibodies can be identified using the complement binding reaction or the 
microimmunofluorescence test.   
Tetracyclines and macrolides are the potentially useful antibiotic types.  
8. Laboratory diagnostics of Chlamydia trachomatis  
C. trachomatis is a biosafety level 2 agent and should be handled appropriately, although it is 
not considered a particularly dangerous pathogen. C. trachomatis urogenital infection in 
women can be diagnosed by testing urine or by collecting swab specimens from the 
endocervix or vagina. Diagnosis of C. trachomatis urethral infection in men can be made by 
testing a urethral swab or urine specimen. Rectal C. trachomatis infections in persons that 
engage in receptive anal intercourse can be diagnosed by testing a rectal swab specimen.  
Today, culture-independent tests have revolutionized chlamydia diagnostics. Comercially 
available antigen detection methods and nucleic acid hybridization tests, when 
introduced in the 1980s, largely replaced the technically more demanding isolation 
procedures (table 3.).  
8.1 Culture 
Although originally chlamydia was grown in embroyonated chicken eggs, growth and 
detection of chlamydia is now accomplished by staining of chlamydial inclusions grown 
in tissue culture cells. The cell line the most commonly used is McCoy cells. The other cell 
lines have been used as well as monkey kidney, HeLa, and HEp-2. It is confirmed that the 
culture is technically difficult and has been shown to be not as sensitive as previously 
thought. Recent studies have indicated that culture sensitivity compared to molecular 
techniques can range from 50-100%, while specificity is considered to be nearly 100%  
(Van Der  Pol et al.,  2001). 
8.2 Non-culture diagnostic test 
Other non-culture diagnostic tests include: direct cytological examination, direct fluorescent 
antibody (DFA) test and antigen detection using the enzyme immunoassay (EIA). 
Cytology was used to detect chlamydial infections before more sensitive tests were 
developed. Specimens obtained from the genital tract were diagnosed for the 
presence/absence of inclusion bodies. The sensitivity of cytology testing is very low with 
only 20% cases being detected.  
DFA using commercial monoclonal antibodies which detect the major outer membrane 
protein (MOMP) of C. trachomatis, which stains only this organism. The test involves the 
specimen swab being rolled onto a glass slide air dried and fixed with methanol. 
Fluorescein-conjugated monoclonal antibody is applied to the slide, which after incubation 
is mounted in mounting medium, coverslipped and read for the presence of EBs with a 
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fluorescent microscope under 1,000 x. The test requires the experience of a trained 
microscopist and has a sensitivity of 80-85% with specificity of 98-99% compared to culture 
(Mahoney &Chernesky, 2003). 
 
Diagnostic method Sensitivity Specificity 
Tissue Culture 70-85% 100% 
Direct Fluorescence Assay 80-85% >99% 
Enzyme Immunoassay 53-76% 95% 
Hybridization (Pace 2) 65-83% 99% 
Ligase Chain Reaction 
Cervical 
Female Urine 
Male Urine  
 
94.4-96.4% 
93-98% 
96.4% 
 
99.5-100% 
99-100% 
94-100% 
Polymerase Chain Reaction (COBAS) 
Cervical  
Female Urine 
Male Urine 
 
89.7% 
89.2% 
90.3% 
 
99.4% 
99.0% 
98.4% 
Strand Displacement Amplification 
Cervical  
Female Urine 
Male Urine 
 
92.8% 
80.5% 
93.1% 
 
98.1% 
98.4% 
93.8% 
Transcriptional Mediated Amplification 
Cervical  
Female Urine 
Male Urine 
Male Urethral  
 
94.2% 
94.7% 
97% 
95.2% 
 
97.6% 
98.9% 
99.1% 
98.2% 
Table 3. Sensitivity and specificity of diagnostic tests for the detection of Chlamydia 
trachomatis. 
EIA was the one of the earliest non-culture developed tests. EIA was widely used before the 
advent of molecular tests and is still used as the most prevalent non-culture detection test 
for chlamydia (Gaydos et al., 1990).There are several EIAs commercially available using 
either polyclonal or monoclonal antibodies to detect chlamydia LPS. The sensitivity of the 
EIAs range from approximately 53-76%, with specificities of about 95%, especially when 
antibody blocking confirmatory assays is used to confirm the positive EIA result. 
Because older non-culture tests, such as DFA and EIA, were traditionally compared to 
culture as a gold standard, the sensitivities reported in the older literature can no longer be 
viewed as accurate. The antigen detection techniques are generally less expensive and easier 
to perform than newer molecular tests.  
8.3 Serology  
The microimmunofluorescence test (MIF) has been the gold standard test for the detection of 
antibody for Chlamydia (Wang et al., 1985). The assay is useful for population studies but is 
not useful for the diagnosis of active C. trachomatis ocular or urogenital disease. 
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8.4 New molecular diagnostic tests for detection of C. trachomatis  
The diagnosis of genital chlamydial infections evolved rapidly from the 1990s. The most 
important advance came from the introduction of nucleic acid amplification tests (NAATs), 
such as polymerase chain reaction (PCR), transcription mediated amplification (TMA), and 
the DNA strand displacement amplification (SDA). NAATs for chlamydia may be 
performed on swab specimens collected from the cervix (women) or urethra (men), on self-
collected vaginal swabs, or on voided urine. Urine and self-collected swab testing facilitates 
the performance of screening tests in settings where genital examination is impractical. At 
present, the NAATs have regulatory approval only for testing urogenital specimens, 
although rapidly evolving research indicates that they may give reliable results on rectal 
specimens.The most sensitive and accurate of the non-culture tests are the NAATs and are 
highly specific, as well. Because they can be used with noninvasively collected specimens 
such as first catch urines from either sex, or vaginal swabs, NAATs are well suited for 
screening as well as diagnosis. There are several types of NAATs. The two most commonly 
used tests are the PCR and LCR tests. These tests offer greatly expanded sensitivities of 
detection, usually well above 90%, while maintaining very high specificity. Choice of test is 
mainly dependent upon cost and preference of the laboratory, as all of these NAATs are 
closely comparable in sensitivity and specificity (Gaydos et al., 2004).  
Because NAATs detect DNA and RNA targets, they do not require viable organisms to 
detect infection.  
9. Diagnosis and treatment 
Chlamydial infections are often asymptomatic, so diagnosis generally requires chlamydia-
specific laboratory test identification or confirmation. Treating infected patients prevents 
sexual transmission of the disease, and treating all sexual partners of those testing positive 
for Chlamydia can prevent reinfection of the index patient and infection of other partners. 
There is no universally accepted protocol for testing the antibiotic susceptibility of C. 
trachomatis.   Because of the unique intracellular characteristics of C. trachomatis, only certain 
antibiotics are effective in treatment. The CDC treatment guidelines for chlamydial 
infections are summarized in tables 4. and 5. (CDC, 2009). 
 
Recommended Regimens 
Azithromycin 1 g orally in a single dose 
or 
Doxycycline 100 mg orally twice a day for 7 days 
 
Alternative Regimens 
Erythromycin base 500 mg orally four times a day for 7 days 
Or 
Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days 
Or 
Levofloxacin 500 mg orally once a day for 7 days 
Or 
Ofloxacin 300 mg orally twice a day for 7 days 
Table 4. Recommended regimens (CDC, 2009). 
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Recommended regimens 
Azithromycin 1 g orally in a single dose 
Or 
Amoxicillin 500 mg orally three times a doa for 7 days 
 
Alternative regimens 
Erythromycin base 500 mg orally four times a day for 7 days 
Or 
Erythromycin base 250 mg orally four times a day for 14 days 
Or 
Erythromycin ethylsuccinate 800 mg orally four times a day for 7 daysbase 
500 mg orally four times a day for 7 days 
Or 
Erythromycin ethylsuccinate 400 mg orally four times a day for 14 days 
Table 5. Recommended regimens in pregnancy (CDC, 2009). 
10. Follow-up 
The validity of chlamydial diagnostic testing at <3 weeks after completion of therapy has 
not been established. False-negative results might occur in the presence of persistent 
infections involving limited numbers of chlamydial organisms, as well as false-positive 
results because of the continued presence of nonviable organisms. 
In addition, NAATs conducted at <3 weeks after completion of therapy in persons who 
were treated successfully could yield false-positive results because oh the continued 
presence of nonviable organisms (CDC, 2009). Routine repeat testing is also encouraged at 
every other examination done 3-12 months after treatment regardless of whether the patient 
believes that her sex partner(s) was treated.  
11. Recommendations for chlamydial screening and re-screening 
In the United States, the CDC recommends that all sexually active adolescent women should 
be screened for chlamydia infection at least annually, even if symptoms are not present. 
Also recommended is annually screening of sexually active women 20-25 years of age and 
older women with risk factors such as a new sex partner or multiple sex partners. 
Since the risk of re-infections is very high, especially in women, the CDC recommends that 
previously infected women are at a high risk and constitute a priority for repeat testing and 
should be re-screened 3-4 months after treatment.  
12. Conclusion 
Chlamydia trachomatis has been recognized as a genital pathogen responsible for an 
increasing variety of clinical syndromes. CT infection is the STD most strongly associated 
with adolescents. Adolescents, young women and men are consistently at higher risk of 
being infected with chlamydia than others. The high level of asymptomaticity and the low 
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levels of testing among females and males make an important reservoir for chlamydial 
infection. Immunity induced by chlamydial infection is not well understood.  
It is clear that single infections will not result in solid immunity to reinfection. Multiple 
infections, homo- or heterotypic, are common.  
Unfortunately, the natural infection is not readily quantifiable in terms of inoculum size, 
and thus relative degrees of immunity may exist which are overcome with a sufficiently 
large challenge.  
In screening studies, younger women are found to have higher cervical infection rates than 
older women, who often have higher antibody levels. In addition, many isolate-negative 
individuals attending STD clinics have IgM to the organism. This antibody may result from 
recent exposure and rapid resolution of the infection or its ablation by an immune response.  
Having in mind that many chlamydial infections are asymptomatic, it has become clear that 
effective control must involve periodic testing of individuals at risk.   
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